Scientific Advisory Committee on Alternative Toxicological Methods; Announcement of Meeting; Request for Comments, 34771-34773 [2021-13919]
Download as PDF
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 123 / Wednesday, June 30, 2021 / Notices
Review, National Institutes of Health, 6701
Rockledge Drive, Room 4120, MSC 7802,
Bethesda, MD 20892, (301) 806–7314,
shahb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Virology.
Date: July 28, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV Molecular Virology, Cell
Biology, Immune and Therapeutic-Focused
Application.
Date: July 28, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Audrey O. Lau, MPH,
Ph.D., Chief Center for Scientific Review,
6701 Rockledge Drive, Bethesda, MD 20892,
(301) 594–4088, audrey.lau@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: July 28, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
IRG Chief, EMNR IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 6182, MSC 7892,
Bethesda, MD 20892, 301–435–2514,
riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Social Sciences and Chronic and
Infectious Disease Epidemiology.
Date: July 28, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, 301–594–
6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Social
Sciences and Chronic and Infectious Disease
Epidemiology.
Date: July 28, 2021.
VerDate Sep<11>2014
17:47 Jun 29, 2021
Jkt 253001
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; UNITE
Transformative Research to Address Health
Disparities and Advance Health Equity at
Minority Serving Institutions (U01).
Date: July 29–30, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aruna K. Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Mycology, Parasitology
and Pathogenesis.
Date: July 29, 2021.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3204,
MSC 7808, Bethesda, MD 20892, 301–496–
6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Endocrinology and
Metabolism.
Date: July 29, 2021.
Time: 10:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liliana N. Berti-Mattera,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 6158,
MSC 7890, Bethesda, MD 20892, (301) 827–
7609, liliana.berti-mattera@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Project: Endocannabinoids as Therapeutic
Targets.
Date: July 29, 2021.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
34771
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Innate and Adaptive Immunology.
Date: July 30, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Innate and Adaptive Immunology.
Date: July 30, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301) 435–
1742, kaushikbasun@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 24, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13942 Filed 6–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Scientific Advisory Committee on
Alternative Toxicological Methods;
Announcement of Meeting; Request
for Comments
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice announces the
next meeting of the Scientific Advisory
Committee on Alternative Toxicological
Methods (SACATM). SACATM is a
federally chartered external advisory
group of scientists from the public and
private sectors, including
SUMMARY:
E:\FR\FM\30JNN1.SGM
30JNN1
jbell on DSKJLSW7X2PROD with NOTICES
34772
Federal Register / Vol. 86, No. 123 / Wednesday, June 30, 2021 / Notices
representatives of regulated industry
and national animal protection
organizations. SACATM advises the
Interagency Coordinating Committee on
the Validation of Alternative Methods
(ICCVAM), the National Toxicology
Program (NTP) Interagency Center for
the Evaluation of Alternative
Toxicological Methods (NICEATM), and
the Director of the National Institute of
Environmental Health Sciences (NIEHS)
and NTP regarding statutorily mandated
duties of ICCVAM and activities of
NICEATM. This SACATM meeting will
be a virtual meeting only and available
to the public for remote viewing.
Registration is required to access the
virtual meeting and to present oral
comments. Information about the
meeting and registration are available at
https://ntp.niehs.nih.gov/go/32822.
DATES:
Meeting: September 28, 2021, 10:00
a.m.–3:30 p.m. EDT; September 29,
2021, 10:00 a.m.–4:00 p.m. EDT. Ending
times are approximate; meeting may end
earlier or run later.
Registration for Virtual Meeting:
Deadline is September 29, 2021, 4:00
p.m. EDT.
Written Public Comment
Submissions: Deadline is September 17,
2021.
Register to Present Oral Comments:
Deadline is September 17, 2021.
Registration to view the virtual
meeting and present oral public
comments is required.
ADDRESSES:
Meeting web page: The preliminary
agenda, registration, and other meeting
materials are at https://
ntp.niehs.nih.gov/go/32822.
Virtual Meeting: The URL for viewing
the virtual meeting will be provided to
those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr.
Sheena Scruggs, Designated Federal
Official for SACATM, Office of Policy,
Review, and Outreach, Division of NTP,
NIEHS, P.O. Box 12233, K2–03,
Research Triangle Park, NC 27709.
Phone: 984–287–3355, Email:
sheena.scruggs@nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2126, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Meeting and Registration: The
meeting is open to the public with time
scheduled for oral public comments.
Due to restrictions on in-person
gatherings amid ongoing public health
concerns, the meeting will be convened
as a virtual meeting.
SACATM will provide input to
ICCVAM, NICEATM, and NIEHS on
programmatic activities and issues.
Preliminary agenda items for the
VerDate Sep<11>2014
17:47 Jun 29, 2021
Jkt 253001
upcoming meeting include: (1) Major
ICCVAM accomplishments in 2021; (2)
regulatory needs and research
applications for ecotoxicity testing; (3)
evolving approaches to validation; and
(4) update on NICEATM computational
resources. Please see the preliminary
agenda for information about specific
presentations.
The preliminary agenda, roster of
SACATM members, background
materials, public comments, and any
additional information will be posted
when available on the SACATM
meeting website (https://
ntp.niehs.nih.gov/go/32822) or may be
requested in hardcopy from the
Designated Federal Official for
SACATM. Following the meeting,
summary minutes will be prepared and
made available on the SACATM
meeting website.
Registration is required to attend the
virtual meeting and is open to all
interested persons. Registrants will
receive instructions on how to access
the virtual meeting in the email
confirming their registration.
Individuals who plan to provide oral
comments (see below) are required to
register online at the SACATM meeting
website (https://ntp.niehs.nih.gov/go/
32822) by September 17, 2021, to
facilitate planning for the meeting.
Individuals are encouraged to visit the
website often to stay abreast of the most
current information regarding the
meeting.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify Ms. Robbin Guy at phone: (984)
287–3136 or email: robbin.guy@nih.gov
in advance of the meeting. TTY users
should contact the Federal TTY Relay
Service at 800–877–8339. Requests
should be made at least five business
days in advance of the event.
Written Public Comments: Written
and oral public comments are invited
for the agenda topics. Guidelines for
public comments are available at
https://ntp.niehs.nih.gov/ntp/about_
ntp/guidelines_public_comments_
508.pdf. The deadline for submission of
written comments is September 17,
2021. Written public comments should
be submitted through the meeting
website. Persons submitting written
comments should include name,
affiliation, mailing address, phone,
email, and sponsoring organization (if
any). Written comments received in
response to this notice will be posted on
the NTP website, and the submitter will
be identified by name, affiliation, and
sponsoring organization (if any).
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Oral Public Comment Registration:
The preliminary agenda allows for
several public comment periods, each
allowing up to six commenters a
maximum of five minutes per speaker.
Registration for oral comments is on or
before September 17, 2021, at https://
ntp.niehs.nih.gov/go/32822. Registration
is on a first-come, first-served basis.
Each organization is allowed one time
slot per comment period. After the
maximum number of speakers per
comment period is exceeded,
individuals registering to submit an oral
comment for the topic will be placed on
a wait list and notified should an
opening become available. Commenters
will be notified after September 17,
2021, to provide logistical information
for their presentations. If possible, oral
public commenters should send a copy
of their slides and/or statement or
talking points to Robbin Guy by email:
guyr2@niehs.nih.gov by September 17,
2021.
Meeting Materials: The preliminary
meeting agenda will be posted when
available on the meeting web page at
https://ntp.niehs.nih.gov/go/32822 and
will be updated one week before the
meeting. Individuals are encouraged to
visit this web page often to stay abreast
of the most current information
regarding the meeting.
Responses to this notice are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in statements
submitted in response to this notice or
presented during the meeting. This
request for input is for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on ICCVAM,
NICEATM, and SACATM: ICCVAM is
an interagency committee composed of
representatives from 17 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability, and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and replace,
reduce, or refine (enhance animal wellbeing and lessen or avoid pain and
distress) animal use.
E:\FR\FM\30JNN1.SGM
30JNN1
Federal Register / Vol. 86, No. 123 / Wednesday, June 30, 2021 / Notices
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of NIEHS and provides the
authority for ICCVAM involvement in
activities relevant to the development of
alternative test methods. Additional
information about ICCVAM can be
found at https://ntp.niehs.nih.gov/go/
iccvam.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts and publishes analyses
and evaluations of data from new,
revised, and alternative testing
approaches. NICEATM and ICCVAM
work collaboratively to evaluate new
and improved testing approaches
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about NICEATM can be
found at https://ntp.niehs.nih.gov/go/
niceatm.
SACATM, established by the ICCVAM
Authorization Act [Section 285l–3(d)],
provides advice on priorities and
activities related to the development,
validation, scientific review, regulatory
acceptance, implementation, and
national and international
harmonization of new, revised, and
alternative toxicological test methods to
ICCVAM, NICEATM, and Director of
NIEHS and NTP. Additional
information about SACATM, including
the charter, roster, and records of past
meetings, can be found at https://
ntp.niehs.nih.gov/go/167.
Dated: June 24, 2021.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2021–13919 Filed 6–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
jbell on DSKJLSW7X2PROD with NOTICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
VerDate Sep<11>2014
17:47 Jun 29, 2021
Jkt 253001
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer at (240) 276–0361.
Project: 2022 National Survey on Drug
Use and Health (OMB No. 0930–0110)
SAMHSA is requesting from the
Office of Management and Budget
(OMB) approval to administer the
National Survey on Drug Use and
Health (NSDUH), a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
NSDUH data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
As certain parts of the United States
reduce COVID–19 restrictions, NSDUH
in-person data collection will proceed
where possible. However, to ensure
sufficient data are collected to produce
nationally representative estimates for
the 2022 survey, NSDUH will continue
to employ a mix of in-person and webbased modes of administration to allow
those respondents living in areas with
COVID–19 restrictions the opportunity
to participate. If the COVID–19
pandemic subsides to such levels to
allow in-person data collection to
resume nationwide, SAMHSA may
reassess that multimode data collection
model as part of the 2022 NSDUH.
In those areas where in-person data
collection is permitted, NSDUH
protocols, processes, and materials will
continue to reflect the need to ensure
the safety of respondents and field
interviewers with respect to COVID–
19—after initial implementation of such
measures beginning in October 2020—
which include equipping field
interviewers with masks, gloves,
disinfecting wipes, and hand sanitizer
for use during data collection and
providing a COVID–19 risk information
form to all respondents.
Unlike previous NSDUHs, a hybrid
address-based sampling (ABS) design
will be implemented for the 2022
NSDUH. ABS refers to the sampling of
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
34773
residential addresses from a list based
on the U.S. Postal Service’s
Computerized Delivery Sequence file. In
areas with high expected ABS coverage,
the ABS frame will be used. In all other
areas, traditional field enumeration will
be used to construct the dwelling unit
frames.
In addition, the NSDUH questionnaire
must be updated periodically to reflect
changing substance use and mental
health issues and to continue producing
current data. For the 2022 NSDUH, the
following questionnaire updates are
planned: (1) Replacing the tobacco
module with a redesigned nicotine
module that includes questions about
vaping, removes low priority items to
reduce respondent burden and
eliminates outdated terminology; (2)
revising the marijuana module to
include questions about the use of CBD,
update questions on the mode of
administration and eliminate outdated
terminology and includes changes to the
market information for marijuana
questions; (3) redesigning the adult and
youth mental health services utilization
modules into one Mental Health Service
Utilization model to remove questions
with outdated terminology and include
questions about newer treatments with
recent increases in popularity; and (4)
replacing the drug treatment module
with a redesigned alcohol and drug
treatment module that includes
questions about newer treatments and
those that have increased in popularity,
as well as eliminating outdated
terminology and reducing respondent
burden.
As with all NSDUH/NHSDA 1 surveys
conducted since 1999, the sample size
of the NSDUH main study for 2022 will
be sufficient to permit prevalence
estimates for each of the fifty states and
the District of Columbia. The total
annual burden estimate for the NSDUH
main study is shown below in Table 1.
1 Prior to 2002, the NSDUH was referred to as the
National Household Survey on Drug Abuse
(NHSDA).
E:\FR\FM\30JNN1.SGM
30JNN1
Agencies
[Federal Register Volume 86, Number 123 (Wednesday, June 30, 2021)]
[Notices]
[Pages 34771-34773]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-13919]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Scientific Advisory Committee on Alternative Toxicological
Methods; Announcement of Meeting; Request for Comments
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the Scientific
Advisory Committee on Alternative Toxicological Methods (SACATM).
SACATM is a federally chartered external advisory group of scientists
from the public and private sectors, including
[[Page 34772]]
representatives of regulated industry and national animal protection
organizations. SACATM advises the Interagency Coordinating Committee on
the Validation of Alternative Methods (ICCVAM), the National Toxicology
Program (NTP) Interagency Center for the Evaluation of Alternative
Toxicological Methods (NICEATM), and the Director of the National
Institute of Environmental Health Sciences (NIEHS) and NTP regarding
statutorily mandated duties of ICCVAM and activities of NICEATM. This
SACATM meeting will be a virtual meeting only and available to the
public for remote viewing. Registration is required to access the
virtual meeting and to present oral comments. Information about the
meeting and registration are available at https://ntp.niehs.nih.gov/go/32822.
DATES:
Meeting: September 28, 2021, 10:00 a.m.-3:30 p.m. EDT; September
29, 2021, 10:00 a.m.-4:00 p.m. EDT. Ending times are approximate;
meeting may end earlier or run later.
Registration for Virtual Meeting: Deadline is September 29, 2021,
4:00 p.m. EDT.
Written Public Comment Submissions: Deadline is September 17, 2021.
Register to Present Oral Comments: Deadline is September 17, 2021.
Registration to view the virtual meeting and present oral public
comments is required.
ADDRESSES:
Meeting web page: The preliminary agenda, registration, and other
meeting materials are at https://ntp.niehs.nih.gov/go/32822.
Virtual Meeting: The URL for viewing the virtual meeting will be
provided to those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr. Sheena Scruggs, Designated Federal
Official for SACATM, Office of Policy, Review, and Outreach, Division
of NTP, NIEHS, P.O. Box 12233, K2-03, Research Triangle Park, NC 27709.
Phone: 984-287-3355, Email: [email protected]. Hand Deliver/
Courier address: 530 Davis Drive, Room K2126, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Meeting and Registration: The meeting is open to the public with
time scheduled for oral public comments. Due to restrictions on in-
person gatherings amid ongoing public health concerns, the meeting will
be convened as a virtual meeting.
SACATM will provide input to ICCVAM, NICEATM, and NIEHS on
programmatic activities and issues. Preliminary agenda items for the
upcoming meeting include: (1) Major ICCVAM accomplishments in 2021; (2)
regulatory needs and research applications for ecotoxicity testing; (3)
evolving approaches to validation; and (4) update on NICEATM
computational resources. Please see the preliminary agenda for
information about specific presentations.
The preliminary agenda, roster of SACATM members, background
materials, public comments, and any additional information will be
posted when available on the SACATM meeting website (https://ntp.niehs.nih.gov/go/32822) or may be requested in hardcopy from the
Designated Federal Official for SACATM. Following the meeting, summary
minutes will be prepared and made available on the SACATM meeting
website.
Registration is required to attend the virtual meeting and is open
to all interested persons. Registrants will receive instructions on how
to access the virtual meeting in the email confirming their
registration. Individuals who plan to provide oral comments (see below)
are required to register online at the SACATM meeting website (https://ntp.niehs.nih.gov/go/32822) by September 17, 2021, to facilitate
planning for the meeting. Individuals are encouraged to visit the
website often to stay abreast of the most current information regarding
the meeting.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify Ms. Robbin Guy at phone: (984) 287-3136 or email:
[email protected] in advance of the meeting. TTY users should contact
the Federal TTY Relay Service at 800-877-8339. Requests should be made
at least five business days in advance of the event.
Written Public Comments: Written and oral public comments are
invited for the agenda topics. Guidelines for public comments are
available at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf. The deadline for submission of
written comments is September 17, 2021. Written public comments should
be submitted through the meeting website. Persons submitting written
comments should include name, affiliation, mailing address, phone,
email, and sponsoring organization (if any). Written comments received
in response to this notice will be posted on the NTP website, and the
submitter will be identified by name, affiliation, and sponsoring
organization (if any).
Oral Public Comment Registration: The preliminary agenda allows for
several public comment periods, each allowing up to six commenters a
maximum of five minutes per speaker. Registration for oral comments is
on or before September 17, 2021, at https://ntp.niehs.nih.gov/go/32822.
Registration is on a first-come, first-served basis. Each organization
is allowed one time slot per comment period. After the maximum number
of speakers per comment period is exceeded, individuals registering to
submit an oral comment for the topic will be placed on a wait list and
notified should an opening become available. Commenters will be
notified after September 17, 2021, to provide logistical information
for their presentations. If possible, oral public commenters should
send a copy of their slides and/or statement or talking points to
Robbin Guy by email: [email protected] by September 17, 2021.
Meeting Materials: The preliminary meeting agenda will be posted
when available on the meeting web page at https://ntp.niehs.nih.gov/go/32822 and will be updated one week before the meeting. Individuals are
encouraged to visit this web page often to stay abreast of the most
current information regarding the meeting.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM, NICEATM, and SACATM: ICCVAM is an
interagency committee composed of representatives from 17 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability, and promotes the scientific validation and regulatory
acceptance of testing methods that more accurately assess the safety
and hazards of chemicals and products and replace, reduce, or refine
(enhance animal well-being and lessen or avoid pain and distress)
animal use.
[[Page 34773]]
The ICCVAM Authorization Act of 2000 (42 U.S.C. 285l-3) establishes
ICCVAM as a permanent interagency committee of NIEHS and provides the
authority for ICCVAM involvement in activities relevant to the
development of alternative test methods. Additional information about
ICCVAM can be found at https://ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative test methods and strategies for
validation studies and technical evaluations. Additional information
about NICEATM can be found at https://ntp.niehs.nih.gov/go/niceatm.
SACATM, established by the ICCVAM Authorization Act [Section 285l-
3(d)], provides advice on priorities and activities related to the
development, validation, scientific review, regulatory acceptance,
implementation, and national and international harmonization of new,
revised, and alternative toxicological test methods to ICCVAM, NICEATM,
and Director of NIEHS and NTP. Additional information about SACATM,
including the charter, roster, and records of past meetings, can be
found at https://ntp.niehs.nih.gov/go/167.
Dated: June 24, 2021.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2021-13919 Filed 6-29-21; 8:45 am]
BILLING CODE 4140-01-P